Veracyte (VCYT) Total Current Liabilities (2012 - 2026)

Veracyte has reported Total Current Liabilities for 15 years, with the latest figure at $62.7 million in Q2 2026.

• Total Current Liabilities for Q2 2026 came in at $62.7 million, down 17.92% year-over-year; the trailing twelve-month figure through Jun 2026 was $62.7 million (down 17.92% YoY), and the FY2025 annual result was $59.9 million, down 23.78% from the prior year.
• Total Current Liabilities rose to $62.7 million in Q2 2026, from $56.1 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $78.6 million in Q4 2024 and troughed at $56.0 million in Q1 2023.
• A 5-year average of $64.3 million and a median of $61.9 million in 2022 frame the typical range for Total Current Liabilities.
• The widest annual swing landed in 2022, when Total Current Liabilities soared 91.21%; it then fell 25.3% in 2026.
• A 5-year view of Total Current Liabilities shows it stood at $62.6 million in 2022, then fell by 2.19% to $61.2 million in 2023, then climbed by 28.4% to $78.6 million in 2024, then fell by 23.78% to $59.9 million in 2025, then climbed by 4.67% to $62.7 million in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $62.7 million in Q2 2026, $56.1 million in Q1 2026, and $59.9 million in Q4 2025.